Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

YUBO INTERNATIONAL BIOTECH LIMITED

(YBGJ)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

YUBO INTERNATIONAL BIOTECH LTD : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)

04/13/2021 | 04:08pm EST

Item 5.03 Amendments to Articles of Incorporation or Bylaws.

Increase in Authorized number of shares of Class A Common Stock

After obtaining the approval of the Board of Directors and the majority stockholders of Yubo International Biotech Limited, a New York corporation (the "Company"), the Company filed a Certificate of Amendment to its Certificate of Incorporation to increase the authorized number of shares of its Class A Common Stock, par value $0.001 per share, from one hundred twenty million (120,000,000) to one billion (1,000,000,000) (the "Authorized Common Stock Amendment"), with a delayed effective date of April 13, 2021. A copy of the Company's Certificate of Incorporation with all Certificate of Amendments thereto, including the Certificate of Amendment filed in connection with the Authorized Common Stock Amendment, is attached hereto as Exhibit 3.1 and incorporated herein by reference. The Authorized Common Stock Amendment was effective April 13, 2021, pursuant to the Certificate of Amendment filed in connection with the Authorized Common Stock Amendment and in accordance with the SEC rules and regulations.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.



Exhibit   Description
  3.1       Certificate of Incorporation of the Registrant with all Certificate of
          Amendments thereto





2

© Edgar Online, source Glimpses

All news about YUBO INTERNATIONAL BIOTECH LIMITED
2021YUBO INTERNATIONAL BIOTECH LTD Management's Discussion and Analysis of Financial Condi..
AQ
2021Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and N..
CI
2021YUBO INTERNATIONAL BIOTECH : Management's Discussion and Analysis of Financial Condition a..
AQ
2021Yubo International Biotech Limited Reports Earnings Results for the Second Quarter Ende..
CI
2021YUBO INTERNATIONAL BIOTECH : Management's Discussion and Analysis of Financial Condition a..
AQ
2021Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended..
CI
2021YUBO INTERNATIONAL BIOTECH : 10-KT - Management's Discussion and Analysis of Financial Con..
AQ
2021YUBO INTERNATIONAL BIOTECH : Financial Statements and Exhibits (form 8-K/A)
AQ
2021YUBO INTERNATIONAL BIOTECH LTD : Amendments to Articles of Inc. or Bylaws; Change in Fisca..
AQ
2021YUBO INTERNATIONAL BIOTECH LTD : Amendments to Articles of Inc. or Bylaws; Change in Fisca..
AQ
More news
Financials (USD)
Sales 2020 1,35  - -
Net income 2020 -0,71 M - -
Net cash 2020 1,07 M - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 48,7 M 48,7 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees -
Free-Float -
Chart YUBO INTERNATIONAL BIOTECH LIMITED
Duration : Period :
Yubo International Biotech Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Jun Wang President, Chief Executive Officer & Director
Lina Liu Chief Financial Officer, Secretary & Treasurer
Wang Yang Director & General Manager
Zhi Hui Bai Director
Sector and Competitors